These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25209730)

  • 1. Transfusion and component characteristics are not associated with allergic transfusion reactions to apheresis platelets.
    Savage WJ; Tobian AA; Savage JH; Hamilton RG; Borge PD; Kaufman RM; Ness PM
    Transfusion; 2015 Feb; 55(2):296-300. PubMed ID: 25209730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atopic predisposition of recipients in allergic transfusion reactions to apheresis platelets.
    Savage WJ; Tobian AA; Savage JH; Hamilton RG; Ness PM
    Transfusion; 2011 Nov; 51(11):2337-42. PubMed ID: 21569041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allergic transfusion reactions to platelets are more commonly associated with prepooled than apheresis components.
    Xiao W; Tormey CA; Capetillo A; Maitta RW
    Vox Sang; 2013 Nov; 105(4):334-40. PubMed ID: 23802769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allergic transfusion reactions to platelets are associated more with recipient and donor factors than with product attributes.
    Savage WJ; Tobian AA; Fuller AK; Wood RA; King KE; Ness PM
    Transfusion; 2011 Aug; 51(8):1716-22. PubMed ID: 21214586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of adverse reaction rates for PAS C versus plasma platelet units.
    Cohn CS; Stubbs J; Schwartz J; Francis R; Goss C; Cushing M; Shaz B; Mair D; Brantigan B; Heaton WA
    Transfusion; 2014 Aug; 54(8):1927-34. PubMed ID: 24735171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergic agonists in apheresis platelet products are associated with allergic transfusion reactions.
    Savage WJ; Savage JH; Tobian AA; Thoburn C; Hamilton RG; Schroeder JT; Ness PM
    Transfusion; 2012 Mar; 52(3):575-81. PubMed ID: 21883267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of acute transfusion reactions to platelets in hospitalized pediatric patients based on the US hemovigilance reporting system.
    Li N; Williams L; Zhou Z; Wu Y
    Transfusion; 2014 Jun; 54(6):1666-72. PubMed ID: 24410992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of donor- and recipient-associated factors to allergic transfusion reactions to platelets.
    Zheng Y; Pei D; Sweat L; Ryan M; Mestemacher MA; Gann M; Cheng C; Geiger TL
    Transfusion; 2021 Mar; 61(3):744-753. PubMed ID: 33314235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of allergic transfusion reactions to platelets and red blood cells through plasma reduction.
    Tobian AA; Savage WJ; Tisch DJ; Thoman S; King KE; Ness PM
    Transfusion; 2011 Aug; 51(8):1676-83. PubMed ID: 21214585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of platelet additive solution apheresis platelets on allergic transfusion reactions and corrected count increment (CME).
    Tobian AA; Fuller AK; Uglik K; Tisch DJ; Borge PD; Benjamin RJ; Ness PM; King KE
    Transfusion; 2014 Jun; 54(6):1523-9; quiz 1522. PubMed ID: 24251374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated exposure rather than the total volume of transfused components may influence the incidence of allergic transfusion reactions.
    Kato H; Nakayama T; Uruma M; Okuyama Y; Handa M; Tomiyama Y; Shimodaira S; Takamoto S
    Transfusion; 2015 Nov; 55(11):2576-81. PubMed ID: 26095126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfusion-related adverse events in the Platelet Dose study.
    Kaufman RM; Assmann SF; Triulzi DJ; Strauss RG; Ness P; Granger S; Slichter SJ
    Transfusion; 2015 Jan; 55(1):144-53. PubMed ID: 25065959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of factors associated with allergic transfusion reaction due to platelet transfusion and the efficacy of platelets resuspended in BRS-A in adult patients.
    Yamanaka M; Yanagisawa R; Kojima S; Nakazawa H; Shimodaira S
    Transfusion; 2019 Nov; 59(11):3405-3412. PubMed ID: 31532542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet concentrate and type II IL-1 receptor are risk factors for allergic transfusion reactions in children.
    Hu W; Feng L; Li M; Li T; Dai Y; Wang X
    Ital J Pediatr; 2020 Jul; 46(1):109. PubMed ID: 32727543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The cost-effectiveness of platelet additive solution to prevent allergic transfusion reactions.
    Kacker S; Ness PM; Savage WJ; Frick KD; McCullough J; King KE; Tobian AA
    Transfusion; 2013 Nov; 53(11):2609-18. PubMed ID: 23363552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between allergic transfusion reactions and allergic predisposition among pediatric patients with hematological/oncological disease.
    Yanagisawa R; Ishimine N; Komori K; Kurata T; Saito S; Tanaka M; Sakashita K; Tozuka M; Nakazawa Y
    Transfusion; 2022 May; 62(5):1035-1044. PubMed ID: 35297063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors related to allergic transfusion reactions and febrile non-haemolytic transfusion reactions in children.
    Yanagisawa R; Shimodaira S; Sakashita K; Hidaka Y; Kojima S; Nishijima F; Hidaka E; Shiohara M; Nakamura T
    Vox Sang; 2016 May; 110(4):376-84. PubMed ID: 26808840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful prevention of severe allergic transfusion reactions with omalizumab.
    Shi S; Han J; Yao Y; Xu Y; Wu D; Wang Y
    Transfusion; 2020 Jul; 60(7):1639-1642. PubMed ID: 32134497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of clinical presentations of allergic transfusion reactions and febrile non-haemolytic transfusion reactions in paediatric patients.
    Yanagisawa R; Tatsuzawa Y; Ono T; Kobayashi J; Tokutake Y; Hidaka E; Sakashita K; Nakamura T
    Vox Sang; 2019 Nov; 114(8):826-834. PubMed ID: 31463954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet transfusions in children: results of a randomized, prospective, crossover trial of plasma removal and a prospective audit of WBC reduction.
    Couban S; Carruthers J; Andreou P; Klama LN; Barr R; Kelton JG; Heddle NM
    Transfusion; 2002 Jun; 42(6):753-8. PubMed ID: 12147029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.